deltatrials
Terminated PHASE2 INTERVENTIONAL 9-arm NCT05370599

Hypertension in Young Adults Trial

Sponsor: University of California, San Francisco

Conditions Hypertension
Interventions Anti-hypertensive agent: Chlorthalidone Anti-hypertensive agent: Losartan Anti-hypertensive agent: amlodipine Home BP monitoring with cuffed device Home BP monitoring with cuffed device + BP patch Home BP monitoring with cuffed device + BP watch
Updated 6 times since 2022 Last updated: Jan 9, 2026 Started: Apr 15, 2022 Primary completion: Jan 7, 2026 Completion: Jan 7, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Funding limitations.

Other terminated trials from University of California, San Francisco

See all terminations from University of California, San Francisco

Other Hypertension trials with similar outcome

Browse all Hypertension trials

Listed as NCT05370599, this PHASE2 trial focuses on Hypertension and remains terminated or withdrawn. Sponsored by University of California, San Francisco, it has been updated 6 times since 2022, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jun 2022 – ~Sep 2023 · 15 months · monthly snapshotRecruiting~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshotRecruiting~Apr 2025 – ~Feb 2026 · 10 months · monthly snapshotActive Not Recruiting~Feb 2026 – present · 7 months · monthly snapshotTerminated

Change History

6 versions recorded

  1. Feb 2026 — Present [monthly]

    Terminated PHASE2

    Status: Active Not Recruiting → Terminated

  2. Apr 2025 — Feb 2026 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  3. Sep 2024 — Apr 2025 [monthly]

    Recruiting PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  5. Sep 2023 — Jul 2024 [monthly]

    Recruiting PHASE2

    Phase: PHASE2_PHASE3 → PHASE2

▶ Show 1 earlier version

  1. Jun 2022 — Sep 2023 [monthly]

    Recruiting PHASE2_PHASE3

    First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of California, San Francisco
Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations